Intra-cellular therapies to present at the canaccord genuity 44th annual growth conference

New york, aug. 08, 2024 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that sharon mates, ph.d., chief executive officer and chairman, is scheduled to present at the canaccord genuity 44th annual growth conference on tuesday, august 13, 2024 at 12:00 p.m. et in boston, ma.
ITCI Ratings Summary
ITCI Quant Ranking